ArticleQuantitative imaging in medicine and surgery2025
Current practice and perceptions of multiparametric magnetic resonance imaging and multiparametric ultrasound and prostatic biopsies for prostate cancer diagnosis in China: a nationwide survey.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Construction of a nomogram model for clinically significant prostate cancer based on biparametric magnetic resonance imaging.International urology and nephrology · 2026Article
- Lack of real-world evidence on active surveillance in Chinese patients with prostate cancer: insights from a 10-year cohort and a physician survey.BMC urology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recently, multiparametric magnetic resonance imaging (mpMRI) and multiparametric ultrasound (mpUS) have been developed to improve prostate cancer (PCa) detection. This study aimed to investigate practice patterns and perceptions among clinicians regarding the use of mpMRI and mpUS as well as prostatic biopsies for PCa diagnosis. Methods: We conducted a national survey via an online questionnaire among urologists, radiologists, and sonographers. The survey collected information on participants' knowledge, routine practices, and perceptions of prostate mpMRI and mpUS, as well as prostatic biopsies. Univariable and multivariable logistic regression analyses were used to identify specialists' characteristics associated with survey responses. Results: There were 354 responses from 144 hospitals were received. The majority (71.4%) of participants performed mpMRI for PCa diagnosis, while a small proportion (15.3%) of them used mpUS. The transperineal ultrasound-guided approach for systematic prostate biopsy was considered as preferable (47.2%). For targeted biopsy, cognitive fusion imaging (71.2%) and MRI-US fusion imaging (62.1%) were clearly favored. Compared with participants in community practices and from central-west region of China, those in academic practices and from east region of China were more likely to report utilization of mpMRI [odds ratio (OR) =2.08 and OR =0.19] and mpUS (OR =0.04 and OR =0.33) and recommendation of MRI targeted biopsy (OR =1.50 and OR =0.15) (P<0.05 in all). Conclusions: The majority of specialists perceived that mpMRI was routinely used, while only a small proportion of them reported the use of mpUS in clinical practice. Participants in academic practices and from east region of China had greater self-reported use of mpMRI and mpUS and recommendation of MRI targeted biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.